Antibiotic susceptibility testing in early and chronic respiratory infections with Pseudomonas aeruginosa

Journal of Cystic Fibrosis

Volumn 12, Issue 3, 2013, Pages 302-

  Foweraker, Juliet E ^a   Govan, John R W ^b  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; BIOFILM; DISK DIFFUSION; EPSILOMETER TEST; HUMAN; LETTER; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; TREATMENT FAILURE;

CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84876955847     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.08.009     Document Type: Letter

References (5)

1. Hurley M.E., Amin Ariff A.H., Bertenshaw C., Bhatt J., Smyth A.R. Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis. J Cyst Fibros 2012, 11:288-292.
2. Foweraker J.E., Laughton C.R., Brown Bilton D. Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing. J Antimicrob Chemother 2005, 55:921-927.
3. Govan J.R.W. Multiresistant pulmonary infection in cystic fibrosis - what does resistant mean?. J Med Microbiol 2006, 55:1615-1617.
4. Macdonald D., Cuthbertson L., Doherty C., Campana S., Revenni N., Taccetti G., et al. Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?. J Antimicrob Chemother 2010, 65:2373-2375.
5. Treggiari M.M., Retsch-Bogart G., Mayer-Hamblett N., Khan U., Kulich M., Kronmal R., et al. Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis. Arch Pediatr Adolesc Med 2011, 165:847-856.